
    
      A pilot study to evaluate the effect of incorporating sublingual sufentanil into our
      perioperative opioid regimen for ambulatory orthopedic surgery. The results will help us
      estimate treatment effect and determine sample size for a subsequent full-scale clinical
      trial.

      Primary Endpoint: total amount of fentanyl consumed during hospital admission. Secondary
      Endpoints: 1) phase I recovery time; and, 2) time to fitness for discharge.

      Exploratory Endpoints 1) pain; 2) time to first request for analgesia; and, 3) incidence of
      nausea and vomiting between the end of anesthesia and hospital discharge.
    
  